Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 27, 2026

Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
06:42

Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications

Published on: September 2, 2025

ASCO-CAP guidelines for breast predictive factor testing: an update.

M Elizabeth Hale Hammond1

  • 1Intermountain Healthcare and University of Utah School of Medicine, Salt Lake City, UT 84143, USA. Elizabeth.hommond@imail.org

Applied Immunohistochemistry & Molecular Morphology : AIMM
|November 18, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global Study on the Accuracy of Human Epidermal Growth Factor Receptor 2-Low Diagnosis in Breast Cancer.

Archives of pathology & laboratory medicine·2024
Same author

In Reply.

Archives of pathology & laboratory medicine·2019
Same author

Reply to C. Murray et al and V. Martin et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2018
Same author

HER2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update Summary.

Journal of oncology practice·2018
Same author

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.

Archives of pathology & laboratory medicine·2018
Same author

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2018
Same journal

ISIMM Page.

Applied immunohistochemistry & molecular morphology : AIMM·2026
Same journal

Clinicopathologic Features of Warthin-Like Subtype of Papillary Thyroid Carcinoma.

Applied immunohistochemistry & molecular morphology : AIMM·2026
Same journal

HER2 In Situ Hybridization: Validation and Implementation of Brightfield Assay in a US Academic Pathology Laboratory.

Applied immunohistochemistry & molecular morphology : AIMM·2026
Same journal

Keratoameloblastoma of the Jaw Bones: Description of 2 Rare Cases and Cytokeratin Profile.

Applied immunohistochemistry & molecular morphology : AIMM·2026
Same journal

Role of Twist and Vimentin as Epithelial-Mesenchymal Transition Biomarkers in Oral Squamous Cell Carcinoma: Relation to Cancer-Associated Fibroblasts.

Applied immunohistochemistry & molecular morphology : AIMM·2026
Same journal

Exploring the Immune Microenvironment for Predicting Immunotherapy Efficacy in Epstein-Barr Virus-Associated Gastric Cancer.

Applied immunohistochemistry & molecular morphology : AIMM·2026
See all related articles

This report compares breast cancer testing guidelines from 2007 and 2011. It focuses on predictive factor testing for human epidermal growth factor receptor 2, estrogen receptor, and progesterone receptor.

Area of Science:

  • Oncology
  • Pathology
  • Clinical Diagnostics

Background:

  • Clinical guidelines are essential for standardized cancer testing.
  • Predictive factor testing in breast cancer informs treatment decisions.

Purpose of the Study:

  • To compare and contrast the American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines for breast cancer predictive factor testing.
  • To highlight changes and updates in guidelines between 2007 and 2011.

Main Methods:

  • Comparative analysis of two ASCO/CAP guideline documents.
  • Review of guidelines published in 2007 (HER2 testing) and 2011 (ER/PR testing).

Main Results:

  • The 2007 guideline focused on human epidermal growth factor receptor 2 (HER2) testing.

Related Experiment Videos

Last Updated: May 27, 2026

Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
06:42

Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications

Published on: September 2, 2025

  • The 2011 guideline addressed estrogen receptor (ER) and progesterone receptor (PR) testing using immunohistochemistry.
  • Both guidelines emphasize standardized testing for predictive factors in breast cancer.

    • Conclusions:

    • Updates in ASCO/CAP guidelines reflect advancements in breast cancer diagnostics.
    • Consistent application of these guidelines is crucial for accurate patient management and targeted therapy.